2015 Press Releases

    Print Page  Close Window
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
11/05/15BioMed Realty Trust Reports Third Quarter 2015 Financial Results
Q3 Gross Leasing Volume of 1.3 Million SF Drives 734,000 SF of Positive Net Absorption during the Quarter SAN DIEGO, Nov. 5, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), investing in the highest quality institutional real estate to meet growing demand across the life science industry, today reported funds from operations (FFO) and core FFO (CFFO) per diluted share of $0.44 for the third quarter ended September 30, 2015, driven by the company's sustained strong leasing, developm... 
Printer Friendly Version
10/08/15BioMed Realty Enters Into Definitive Agreement To Be Acquired By Blackstone For $23.75 Per Share In $8 Billion Transaction
SAN DIEGO, Oct. 8, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that it has entered into a definitive agreement with affiliates of Blackstone Real Estate Partners VIII, under which Blackstone will acquire all outstanding shares of common stock of BioMed Realty for $23.75 per share in an all-cash transaction valued at $8 billion.  The transaction has been unanimously approved by BioMed Realty's Board of Directors and represents a premium of approximately 24% ov... 
Printer Friendly Version
09/15/15BioMed Realty Trust Declares Third Quarter 2015 Common Stock Dividend
SAN DIEGO, Sept. 15, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a third quarter 2015 dividend of $0.26 per share of common stock. The dividend is equivalent to an annualized dividend of $1.04 per common share. The common stock dividend is payable on October 15, 2015 to stockholders of record at the close of business on September 30, 2015.  About BioMed Realty Trust BioMed Realty invests in the highest quality ins... 
Printer Friendly Version
07/28/15BioMed Realty Trust Reports Second Quarter 2015 Financial Results
Company Reports FFO and Core FFO of $0.58 for Second Quarter Driven by Accelerating Cash Flows from Strong Leasing Momentum and Investment Returns SAN DIEGO, July 28, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), investing in the highest quality institutional real estate to meet growing demand across the life science industry, today reported funds from operations (FFO) and core FFO (CFFO) per d... 
Printer Friendly Version
07/16/15BioMed Realty Trust to Report Second Quarter 2015 Results
SAN DIEGO, July 16, 2015 (GLOBE NEWSWIRE) -- BioMed Realty Trust, Inc. (NYSE:BMR) today announced it will report results for its second quarter ended June 30, 2015 after the market closes on Tuesday, July 28, 2015. Alan D. Gold, Chairman, President and Chief Executive Officer, and other members of the BioMed Realty management team will host an investor conference call at 10:00 a.m. Pacific Time on Wednesday, July 29, 2015 to discuss the company's financial results and operations for the quar... 
Printer Friendly Version
06/25/15BioMed Realty And Illumina Announce New Build-To-Suit Laboratory Building In Cambridge's Growing Life Science Cluster
New State-of-the-Art Building To Be Located in Scientific Research Park, Granta Park, and Will Serve As Illumina's New European Headquarters SAN DIEGO, June 25, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that Illumina, Inc. (NASDAQ: ILMN), a world leader in genomics focused on improving human health by unlocking the power of the genome, has signed a 20-year lease for a 155,000 square foot new and innovative scientific research building in Cambridge, England. Th... 
Printer Friendly Version
06/15/15BioMed Realty Trust Declares Second Quarter 2015 Common Stock Dividend
SAN DIEGO, June 15, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a second quarter 2015 dividend of $0.26 per share of common stock. The dividend is equivalent to an annualized dividend of $1.04 per common share. The common stock dividend is payable on July 15, 2015 to stockholders of record at the close of business on June 30, 2015.  About BioMed Realty Trust BioMed Realty, with its trusted expertise and valuable r... 
Printer Friendly Version
06/09/15BioMed Realty Trust To Present At REITWeek 2015
SAN DIEGO, June 9, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that Alan Gold, Chairman, President and Chief Executive Officer, and Greg Lubushkin, Chief Financial Officer, will present at REITWeek® 2015: NAREIT's Investor Forum in New York City on Wednesday, June 10, 2015 at approximately 9:30 a.m. Eastern. A live webcast of the presentation will be available to all investors by accessing the company's website at www.biomedrealty.com. The complete webcast will... 
Printer Friendly Version
05/29/15BioMed Realty Trust Sells King of Prussia Property in Radnor to Penn Medicine for $35 Million
Company To Redeploy Capital Into Growing Core Innovation Markets SAN DIEGO--(BUSINESS WIRE)--May 29, 2015-- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the completion of the sale of its property at 145 King of Prussia Road in Radnor, PA to Penn Medicine for $35 million. This deal will allow Penn Medicine to develop its own plan for the site in partnership with the Radnor Township. The transaction will result in an approximate... 
Printer Friendly Version
04/28/15BioMed Realty Trust Reports First Quarter 2015 Financial Results
Strong Gross Leasing Continues with 780,800 Square Feet During the Quarter SAN DIEGO, April 28, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), the leading real estate company focusing on life sciences, today reported funds from operations (FFO) and core FFO (CFFO) per diluted share of $0.41 for the first quarter ended March 31, 2015, driven by over three million square feet of gross leasing over the past four quarters. First Quarter Highlights Demand throughout the compa... 
Printer Friendly Version
04/20/15BioMed Realty Earns Upgraded Investment Grade Corporate Credit Rating From Moody's Investors Service
Rating Improves to Baa2 with Stable Outlook SAN DIEGO, April 20, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its investment grade corporate credit rating from Moody's Investors Service (Moody's) has been upgraded to Baa2 from Baa3. BioMed Realty was the first real estate investment trust dedicated to the life science industry to receive investment grade corporate credit ratings from Moody's and Standard & Poor's Ratings Services in April 2010. The compa... 
Printer Friendly Version
04/17/15BioMed Realty Trust to Report First Quarter 2015 Results
SAN DIEGO, April 17, 2015 (GLOBE NEWSWIRE) -- BioMed Realty Trust, Inc. (NYSE:BMR) today announced it will report results for its first quarter ended March 31, 2015 after the market closes on Tuesday, April 28, 2015. Alan D. Gold, Chairman, President and Chief Executive Officer, and other members of the BioMed Realty management team will host an investor conference call at 10:00 a.m. Pacific Time on Wednesday, April 29, 2015 to discuss the company's financial results and operations for the q... 
Printer Friendly Version
04/15/15BioMed Realty Launches Its 2014 Online Annual Report On Another Record-Breaking Year
Site Offers State-Of-The-Art Design and Navigation, Focused Digital Content and Easily Downloadable Information SAN DIEGO, April 15, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that its 2014 Online Annual Report and other proxy materials are now available at http://www.biomedrealty.com/14AR. Titled "The Next 10 Years," the 2014 Online Annual Report explores the company's outstanding results in 2014 and vision for 2015 and beyond. In addition, the site examin... 
Printer Friendly Version
04/06/15BioMed Realty Signs Alnylam Pharmaceuticals To 295,000 Square Foot Lease For Class A Laboratory And Office Space In Cambridge
RNAi Pioneer Taking Entire 675 West Kendall Laboratory and Office Building to Accommodate Growing R&D Efforts CAMBRIDGE, Mass., April 6, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a 295,000 square foot lease at 675 West Kendall by Alnylam Pharmaceuticals in Cambridge, Massachusetts providing Alnylam with Class A laboratory and office space in the heart of Kendall Square. Alnylam Pharmaceuticals is leading the translation of RNAi as a new c... 
Printer Friendly Version
04/02/15BioMed Realty Continues Leasing Momentum In Cambridge By Signing Biogen To 80,000 Square Feet
Biogen Expansion Pushes BioMed Realty's 301 Binney Property to 100 Percent Occupied CAMBRIDGE, Mass., April 2, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) continues the strong leasing in March with the announcement of a new ten-year lease with Biogen for approximately 80,000 square feet of Class A laboratory and office space at the company's 301 Binney Street property in Cambridge, Massachusetts. Biogen develops, markets and manufactures therapies for people living with serious... 
Printer Friendly Version
04/02/15BioMed Realty Forms New Relationship With Stanford Health Care With New 138,000 Square Foot Lease At Pacific Research Center
Company's Leasing Momentum in Bay Area Continues as Newark Campus Now Approximately 80% Leased with Addition of Premier Bay Area Health Care Institution SAN DIEGO, April 2, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that Stanford Health Care has leased 138,000 square feet at the company's Pacific Research Center (PRC) in Newark, California. This new 104-month lease adds Stanford Health Care to BioMed Realty's strong roster of premier research institutions and u... 
Printer Friendly Version
03/25/15BioMed Realty Leases Akamai Technologies 67,000 Square Feet At 50 Hampshire Property In The Cambridge Innovation District
With the New Lease by Akamai, BioMed Realty Has Already Forward-Leased Over 50 Percent of the Cambridge Property Before Current Tenant Vacates the Building CAMBRIDGE, Mass., March 25, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a new ten-year lease with Akamai Technologies for approximately 67,000 square feet at 50 Hampshire in Cambridge, Massachusetts. Akamai Technologies is a leading provider of cloud services to help enterprises deliver innovat... 
Printer Friendly Version
03/18/15BioMed Realty Trust Signs Reed Elsevier To Expand In Cambridge Into 33,500 Square Feet In Company's 50 Hampshire Property
International Information Solutions Company to be First New Tenant as They Grow and Expand in East Cambridge CAMBRIDGE, Mass., March 18, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a new ten-year lease for approximately 33,500 square feet at 50 Hampshire with Reed Elsevier, a world-leading provider of information solutions serving scientific, technical and medical businesses . The lease marks the first at the Cambridge property bei... 
Printer Friendly Version
03/16/15BioMed Realty Trust Declares First Quarter 2015 Common Stock Dividend
SAN DIEGO, March 16, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a first quarter 2015 dividend of $0.26 per share of common stock. The dividend is equivalent to an annualized dividend of $1.04 per common share. The common stock dividend is payable on April 15, 2015 to stockholders of record at the close of business on March 31, 2015.  About BioMed Realty Trust BioMed Realty, with its trusted expertise and valuable... 
Printer Friendly Version
03/10/15Wexford Science + Technology And University City Science Center Announce That Anchor Tenant Penn Medicine University City Is Expanding To Two Additional Floors At New 3737 Science Building
New Life Science Building in West Philadelphia Receives LEED Gold Certification For Its Innovative Design and Energy Optimization PHILADELPHIA, March 10, 2015 /PRNewswire/ -- Wexford Science + Technology, a BioMed Realty (NYSE: BMR) company, and the University City Science Center today announced that, Penn Medicine University City, has agreed to expand into an additional 56,000 square feet or two entire floors at the recently opened 3737 Science Center Building. With this lease expans... 
Printer Friendly Version
03/03/15BioMed Realty Trust to Present at Citi 2015 Global Property CEO Conference
SAN DIEGO, March 3, 2015 /PRNewswire/ --  BioMed Realty Trust, Inc. (NYSE: BMR) announced today that Alan Gold, Chairman, President and Chief Executive Officer, and Greg Lubushkin, Chief Financial Officer, will present at the Citi 2015 Global Property CEO Conference in Hollywood, Florida at approximately 10:10 a.m. Eastern Time on Wednesday, March 4, 2015. Key topics will include the company's growth strategy focused on the intersection of the growing health care sector and innovation and the bu... 
Printer Friendly Version
03/02/15BioMed Realty Gets Back 313,000 Square Feet Of Valuable Real Estate In Cambridge Innovation District
Company Announces Termination of Vertex Leases in Cambridgeport, Including Termination Fee of $14 Million SAN DIEGO, March 2, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it has recaptured approximately 313,000 square feet of space in the most dynamic and valuable life science real estate market in the world through the termination of Vertex Pharmaceuticals' leases on three properties in Cambridge, Massachusetts effective February 28, 2015. BioMed Realty will rec... 
Printer Friendly Version
02/25/15BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value
As Part of Realignment, Company Announces Departure of Kent Griffin, President & Chief Operating Officer SAN DIEGO, Feb. 25, 2015 /PRNewswire/ -- Today, BioMed Realty Trust, Inc. (NYSE: BMR) announced a realignment, including a number of promotions and additions to its leadership team focused on the execution of the company's strategy to increase shareholder returns through strategic investments in real estate at the intersection of the growing health care industry and the innovation sect... 
Printer Friendly Version
02/12/15BioMed Realty Breaks Ground On i3, A New 316,000 Square Foot Iconic Development In San Diego, To Meet The Needs Of The Dynamic Life Science Industry
New State-of-the-Art Laboratory and Office Campus Is Designed to Become the Destination for Life Science in San Diego by Promoting Collaboration and Groundbreaking Science SAN DIEGO, Feb. 12, 2015 /PRNewswire/ -- Joined by San Diego political leaders and representatives of the life science community, BioMed Realty Trust, Inc. (NYSE: BMR) today broke ground on a new 316,000 square foot laboratory and office campus designed to meet the unique real estate needs of San Diego's thriving life scien... 
Printer Friendly Version
02/04/15BioMed Realty Trust Reports Fourth Quarter And Full-Year 2014 Financial Results
New Full-Year Leasing Record of 2.8 Million SF and New Strategic Investments Driving Increased FFO Guidance for 2015 SAN DIEGO, Feb. 4, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), the leading real estate company focusing on life sciences, today announced funds from operations (FFO) and core FFO (CFFO) per diluted share of $0.35 and $0.36 for the fourth quarter ended December 31, 2014, respectively, and reported approximately 876,000 square feet of gross leasing from 34 leasing... 
Printer Friendly Version
02/03/15BioMed Realty Expands Leadership Position In Seattle's South Lake Union Innovation District With $90 Million Investment In Core Life Science Research Facility
The 116,200 Square Foot Class A Laboratory and Office Facility Serves as the Headquarters and Primary Research Center for World Renowned Seattle Biomedical Research Institution SAN DIEGO, Feb. 3, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that it is under contract to acquire the 307 Westlake Avenue North building in the heart of the burgeoning South Lake Union life science market of Se... 
Printer Friendly Version
01/21/15BioMed Realty Trust to Report 2014 Fourth Quarter and Full-Year Results
SAN DIEGO, Jan. 21, 2015 (GLOBE NEWSWIRE) -- BioMed Realty Trust, Inc. (NYSE:BMR) today announced it will report results for its fourth quarter and year ended December 31, 2014 after the market closes on Wednesday, February 4, 2015. Alan D. Gold, Chairman and Chief Executive Officer, and other members of the BioMed Realty management team will host an investor conference call at 8:00 a.m. Pacific Time on Thursday, February 5, 2015 to discuss the company's financial results and operations for ... 
Printer Friendly Version
01/16/15BioMed Realty Trust Announces Tax Treatment Of 2014 Distributions
SAN DIEGO, Jan. 16, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE:BMR) today announced the tax treatment of its 2014 distributions. The following table summarizes, for income tax purposes, the nature of the cash distributions paid by the company to stockholders during the year ended December 31, 2014 and the appropriate 1099DIV box number:   Security Description: Common Stock CUSIP: 09063H107 Ticker Symbol: BMR Record Date Payable ... 
Printer Friendly Version
01/05/15BioMed Realty And Illumina To Create New 360,000 Square Foot World-Class Life Science Campus In Foster City, CA
Development of New State-of-the-Art Campus Marks One of the Largest Life Science Lease Transactions Ever in the U.S. as Illumina Continues Its Rapid Growth SAN DIEGO, Jan. 5, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that Illumina, Inc. (NASDAQ: ILMN), a world leader in genomics, has signed a 15-year lease for a new 360,000 square foot, state-of-the-art, build-to-suit campus in Foster City, CA. This agreement represents one of the largest life science lease tr... 
Printer Friendly Version